Ipsen SA annual ebitda
2022
2023
2024
2025
Ipsen SA EBITDA Growth & History (IPN)
Ipsen SA's calculated EBITDA was €1.25B for fiscal 2025.
View full Ipsen SA company overviewIpsen SA annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €1.25B | €68.8M | +5.83% |
| 2024 | 2024-12-31 | €1.18B | €172.6M | +17.15% |
| 2023 | 2023-12-31 | €1.01B | −€66.4M | −6.19% |
| 2022 | 2022-12-31 | €1.07B | — | — |
Ipsen SA ebitda trends
Between the periods ended 2022-12-31 and 2025-12-31, Ipsen SA's ebitda increased from €1.07B to €1.25B, a change of €175.0M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ipsen SA source filings ↗Community posts
Ipsen lifts annual growth and margin forecasts after strong drug sales
Ipsen ($IPN) raised its 2026 sales-growth target to approximately 23% at constant exchange rates, from more than 20%, and its core operating-margin forecast to around 39%, from above 37%. Third-quarter revenue reached €1.17 billion, increas ...
